These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 8185754)

  • 41. The GO License: only part of the solution.
    Batson A; Milstien JB
    Health Aff (Millwood); 2008; 27(1):140-2. PubMed ID: 18180489
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Drugs for the developing world.
    GMHC Treat Issues; 1997-1998 Winter; 12(1):32. PubMed ID: 11364989
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Reprivatizing pharmaceutical supplies in Africa.
    Turshen M
    J Public Health Policy; 2001; 22(2):198-225. PubMed ID: 11469153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. International. Rights group: U.S. blocking access to generic AIDS drugs.
    AIDS Policy Law; 2004 Apr; 19(7):1, 4. PubMed ID: 15124593
    [No Abstract]   [Full Text] [Related]  

  • 45. Making drugs accessible.
    Association La Bergerie
    AIDS Action; 1999; (43):5. PubMed ID: 12349193
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.
    Pablos-Mendez A; Gowda DK; Frieden TR
    Bull World Health Organ; 2002; 80(6):489-95; discussion 495-500. PubMed ID: 12132008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pharmaceutical policy of the Andean sub-region.
    Essent Drugs Monit; 1993; (16):13-5. PubMed ID: 12319050
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New frontier of AIDS activism: international trade rules and global access to medicines. Interview by John S. James.
    Sawyer E
    AIDS Treat News; 1999 Apr; (No 317):1, 5-8. PubMed ID: 11366992
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration.
    Hogerzeil HV; Liberman J; Wirtz VJ; Kishore SP; Selvaraj S; Kiddell-Monroe R; Mwangi-Powell FN; von Schoen-Angerer T;
    Lancet; 2013 Feb; 381(9867):680-9. PubMed ID: 23410612
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The use of essential drugs. Third report of the WHO Expert Committee.
    Bull Int Union Tuberc Lung Dis; 1989 Jun; 64(2):45-6. PubMed ID: 2790287
    [No Abstract]   [Full Text] [Related]  

  • 51. WHO's essential drugs concept.
    Lancet; 1990 Apr; 335(8696):1003-4. PubMed ID: 1970066
    [No Abstract]   [Full Text] [Related]  

  • 52. The use of essential drugs. Report of a WHO expert committee.
    World Health Organ Tech Rep Ser; 1983; 685():1-46. PubMed ID: 6408810
    [No Abstract]   [Full Text] [Related]  

  • 53. [Stopping the use of unused drugs for humanitarian purposes: Stakes and perspectives].
    Aloy B; Siranyan V; Dussart C
    Ann Pharm Fr; 2009 Nov; 67(6):414-8. PubMed ID: 19900605
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The use of essential drugs. Third report of the WHO Expert Committee.
    World Health Organ Tech Rep Ser; 1988; 770():1-63. PubMed ID: 3140500
    [No Abstract]   [Full Text] [Related]  

  • 55. [Improve the accessibility of essential drugs for the populations of one medical region in Burkina Faso].
    Ridde V; Nitièma AP; Dadjoari M
    Sante; 2005; 15(3):175-82. PubMed ID: 16207580
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Drugs for the poor of the Third World: consumption and distribution.
    Mills A; Walker GJ
    J Trop Med Hyg; 1983 Aug; 86(4):139-45. PubMed ID: 6668634
    [No Abstract]   [Full Text] [Related]  

  • 57. A vital link. Ensuring supplies of medical equipment and drugs where really needed.
    Lane NS
    WHO Chron; 1977 Oct; 31(10):404-7. PubMed ID: 930056
    [No Abstract]   [Full Text] [Related]  

  • 58. A review of essential drugs and primary health care. What are the important next steps?
    Lohse AW; Vaughan JP
    J Trop Med Hyg; 1983 Aug; 86(4):131-7. PubMed ID: 6668633
    [No Abstract]   [Full Text] [Related]  

  • 59. How do patents and economic policies affect access to essential medicines in developing countries?
    Attaran A
    Health Aff (Millwood); 2004; 23(3):155-66. PubMed ID: 15160813
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Patent rules must not hinder access to cheap drugs in poor countries, experts say.
    Zarocostas J
    BMJ; 2011 Feb; 342():d1219. PubMed ID: 21343204
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.